Phosphodiesterase type 5 inhibitors for penile rehabilitation post radical prostatectomy a review of clinical effectiveness and guidelines

The objective of this Rapid Response report is to evaluate the efficacy of phosphodiesterase 5 inhibitors (PDE-5Is) for penile rehabilitation following radical prostatectomy (RP), and to identify evidence-based guidelines associated with penile rehabilitation following RP.

Bibliographic Details
Main Authors: Kaulback, Kellee, Argáez, Charlene (Author)
Corporate Author: Canadian Agency for Drugs and Technologies in Health
Format: eBook
Language:English
Published: Ottawa Canadian Agency for Drugs and Technologies in Health 2017, August 24, 2017
Edition:Version 1.0
Series:CADTH rapid response report: summary with critical appraisal
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Description
Summary:The objective of this Rapid Response report is to evaluate the efficacy of phosphodiesterase 5 inhibitors (PDE-5Is) for penile rehabilitation following radical prostatectomy (RP), and to identify evidence-based guidelines associated with penile rehabilitation following RP.
Physical Description:1 PDF file (39 pages) illustration